Avalyn Pharma Inc. · NASDAQ:AVLN
Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. converted 1,275,486 Avalyn Pharma Inc. shares (Form 4)
Traded May 1, 2026 · Filed May 1, 2026
On May 1, 2026, Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. (10% owner) converted 1,275,486 Avalyn Pharma Inc. shares, leaving 1,275,486 shares. Filed May 1, 2026 (Form 4).
- Converted
- 1,275,486 shares
- Holding after
- 1,275,486 shares
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | Conversion | 1,275,486 | 1,275,486 | Direct |
Source
Related
- Avalyn Pharma Inc.
- Wellington Biomedical Innovation Master Investors (Cayman) II, L.P.
- Avalyn Pharma Inc. shareholders
- Schedule 13G · Novo Holdings A/S · Aug 14, 2026
- Schedule 13G · Norwest Venture Partners XV, LP · Aug 11, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13D · Montanova Capital, LLC · May 8, 2026
- Schedule 13D · SR One Capital Management, LLC · May 8, 2026